Neurocrine Biosciences, Inc. v. Crystal Pharmaceutical (Suzhou) Co., Ltd. et al
Defendant: Crystal Pharmatech Co., Ltd.
Counter Defendant: Neurocrine Biosciences, Inc.
Counter Claimant: Crystal Pharmaceutical (Suzhou) Co., Ltd.
Case Number: 1:2021cv01464
Filed: October 18, 2021
Court: US District Court for the District of Delaware
Presiding Judge: Maryellen Noreika
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35 U.S.C. ยง 271
Jury Demanded By: None
Docket Report

This docket was last retrieved on December 13, 2021. A more recent docket listing may be available from PACER.

Date Filed Document Text
December 13, 2021 Pro Hac Vice Attorney C. Kyle Musgrove for Crystal Pharmaceutical (Suzhou) Co., Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (smg)
December 10, 2021 Filing 9 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Crystal Pharmatech Co., Ltd. for Crystal Pharmaceutical (Suzhou) Co., Ltd. filed by Crystal Pharmaceutical (Suzhou) Co., Ltd.. (Phillips, John)
December 10, 2021 Filing 8 ANSWER to #1 Complaint, Affirmative Defenses, COUNTERCLAIM against Neurocrine Biosciences, Inc. by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Phillips, John) Modified on 12/10/2021 (mdb).
December 9, 2021 Pro Hac Vice Attorney Scott A. Cunning, II for Crystal Pharmaceutical (Suzhou) Co., Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk)
November 12, 2021 Opinion or Order SO ORDERED, re #7 MOTION for Pro Hac Vice Appearance of Attorney Scott A. Cunning II, C. Kyle Musgrove and Elizabeth M. Crompton filed by Crystal Pharmaceutical (Suzhou) Co., Ltd.. ORDERED by Judge Maryellen Noreika on 11/12/2021. (mdb)
November 12, 2021 Opinion or Order SO ORDERED, re #6 Stipulation Regarding Waiver of Service and Establishment of Answer Deadline filed by Neurocrine Biosciences, Inc., Set/Reset Answer Deadlines: Crystal Pharmaceutical (Suzhou) Co., Ltd. answer due 12/10/2021; Crystal Pharmatech Co., Ltd. answer due 12/10/2021. ORDERED by Judge Maryellen Noreika on 11/12/2021. (mdb)
November 11, 2021 Filing 7 MOTION for Pro Hac Vice Appearance of Attorney Scott A. Cunning II, C. Kyle Musgrove and Elizabeth M. Crompton - filed by Crystal Pharmaceutical (Suzhou) Co., Ltd.. (Bilson, David)
November 11, 2021 Filing 6 STIPULATION Regarding Waiver of Service and Establishment of Answer Deadline for Defendant Crystal Pharmaceutical (Suzhou) Co., Ltd., by Neurocrine Biosciences, Inc.. (Balick, Steven)
October 20, 2021 Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (nms)
October 18, 2021 Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Neurocrine Biosciences, Inc.. (twk)
October 18, 2021 Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,993,941; 11,026,931; 11,026,939; 11,040,029. (twk)
October 18, 2021 Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received First Notice: September 7, 2021. Date of Expiration of the 941 Patent: October 10, 2037. Date of Expiration of the 931 Patent: August 14, 2039. Date of Expiration of the 029 Patent: October 10, 2037. Date of Expiration of the 939 Patent: September 18, 2038. (twk)
October 18, 2021 Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk)
October 18, 2021 Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Crystal Pharmaceutical (Suzhou) Co., Ltd., Crystal Pharmatech Co., Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3723489.) - filed by Neurocrine Biosciences, Inc.. (Attachments: #1 Exhibit A-D, #2 Civil Cover Sheet)(twk)
October 18, 2021 No Summons Issued. (twk)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Neurocrine Biosciences, Inc. v. Crystal Pharmaceutical (Suzhou) Co., Ltd. et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Counter defendant: Neurocrine Biosciences, Inc.
Represented By: Steven J. Balick
Represented By: Andrew Colin Mayo
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Counter claimant: Crystal Pharmaceutical (Suzhou) Co., Ltd.
Represented By: John C. Phillips, Jr.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Crystal Pharmatech Co., Ltd.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?